NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JAPIC ID: JapicCTI-142509

Registered date:

Basic Information

Recruitment status
Health condition(s) or Problem(s) studiedinfluenza prevention
Date of first enrollment24/3/2014
Target sample size55
Countries of recruitment
Study typeINTERVENTIONAL
Intervention(s)Intervention name : BK-FLU Dosage And administration of the intervention : Subcutaneously administer 0.5 mL of BK-FLU twice with interval of 1-4 weeks between administrations. Control intervention name : null

Outcome(s)

Primary OutcomeSafety
Secondary OutcomeImmunogenicity

Key inclusion & exclusion criteria

Age minimum20
Age maximum64
GenderBOTH
Include criteriahealthy Japanese adult
Exclude criteriaSubjects with history of influenza within 6 months Subjects with history of influenza vaccination within 6 months

Related Information

Contact

public contact
Name The Research Foundation for Microbial Diseases of Osaka University Clini(continued to "Affiliation")
Address 06-6877-4812
Telephone
E-mail
Affiliation cal Development section Clinical Development Depertment Reserch And Development Division
scientific contact
Name
Address
Telephone
E-mail
Affiliation